BioLife Solutions Company Insiders
BLFS Stock | USD 26.01 0.62 2.44% |
BioLife Solutions' insiders are aggressively selling. The analysis of insiders' sentiment of trading BioLife Solutions stock suggests that vertually all insiders are panicking at this time. BioLife Solutions employs about 409 people. The company is managed by 10 executives with a total tenure of roughly 43 years, averaging almost 4.0 years of service per executive, having 40.9 employees per reported executive.
Michael Rice CEO CEO and President and Director |
Aby Mathew Chairman Chairman of Scientific Advisory Board, CTO and Sr. VP |
BioLife Solutions' Insider Buying Vs Selling
0
Selling | Buying |
Latest Trades
2024-11-18 | Aby J Mathew | Disposed 17604 @ 20.05 | View | ||
2024-11-15 | Aby J Mathew | Disposed 25000 @ 21.17 | View | ||
2024-11-12 | Troy Wichterman | Disposed 147 @ 26.19 | View | ||
2024-10-30 | Troy Wichterman | Disposed 894 @ 23.15 | View | ||
2024-10-15 | Aby J Mathew | Disposed 10000 @ 23.28 | View | ||
2024-09-18 | Aby J Mathew | Disposed 10000 @ 23.9 | View | ||
2024-09-16 | Troy Wichterman | Disposed 611 @ 25.12 | View | ||
2024-08-21 | Todd Berard | Disposed 82 @ 25.61 | View |
Monitoring BioLife Solutions' insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
BioLife |
BioLife Solutions' Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with BioLife Solutions' future performance. Based on our forecasts, it is anticipated that BioLife will maintain a workforce of slightly above 410 employees by December 2024.BioLife Solutions Management Team Effectiveness
The company has return on total asset (ROA) of (0.0597) % which means that it has lost $0.0597 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1504) %, meaning that it created substantial loss on money invested by shareholders. BioLife Solutions' management efficiency ratios could be used to measure how well BioLife Solutions manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.42 in 2024. Return On Capital Employed is likely to drop to -0.2 in 2024. At this time, BioLife Solutions' Total Assets are comparatively stable compared to the past year. Non Current Assets Total is likely to gain to about 306.7 M in 2024, whereas Intangible Assets are likely to drop slightly above 19.5 M in 2024.Common Stock Shares Outstanding is likely to gain to about 45.9 M in 2024, despite the fact that Net Loss is likely to grow to (119.5 M).
BioLife Solutions Workforce Comparison
BioLife Solutions is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 124,714. BioLife Solutions adds roughly 409 in number of employees claiming only tiny portion of equities under Health Care industry.
BioLife Solutions Profit Margins
The company has Profit Margin (PM) of (0.31) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.05) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.05.Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Gross Profit Margin | 0.55 | 0.3263 |
|
|
BioLife Solutions Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific BioLife Solutions insiders, such as employees or executives, is commonly permitted as long as it does not rely on BioLife Solutions' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, BioLife Solutions insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
---|---|---|---|---|---|
2024-12-01 | 0.1176 | 2 | 17 | 20,000 | 95,263 |
2024-09-01 | 0.0455 | 1 | 22 | 10,000 | 50,537 |
2024-06-01 | 0.0476 | 1 | 21 | 150,000 | 189,728 |
2024-03-01 | 0.5 | 18 | 36 | 338,143 | 70,504 |
2023-12-01 | 2.5625 | 41 | 16 | 1,769,388 | 112,679 |
2023-09-01 | 0.6071 | 17 | 28 | 76,724 | 50,158 |
2023-06-01 | 0.1633 | 8 | 49 | 180,000 | 181,605 |
2023-03-01 | 0.678 | 40 | 59 | 614,079 | 215,711 |
2022-09-01 | 1.45 | 29 | 20 | 21,041 | 19,449 |
2022-06-01 | 0.8286 | 29 | 35 | 277,202 | 377,377 |
2022-03-01 | 0.5682 | 25 | 44 | 490,275 | 277,951 |
2021-12-01 | 0.2639 | 19 | 72 | 161,036 | 498,596 |
2021-09-01 | 0.3077 | 20 | 65 | 430,956 | 497,668 |
2021-06-01 | 0.4478 | 30 | 67 | 284,791 | 482,853 |
2021-03-01 | 0.3836 | 28 | 73 | 341,409 | 825,538 |
2020-12-01 | 0.2075 | 11 | 53 | 1,676,211 | 2,984,870 |
2020-09-01 | 0.25 | 8 | 32 | 1,273,457 | 767,468 |
2020-06-01 | 0.3548 | 11 | 31 | 6,347,358 | 5,757,080 |
2020-03-01 | 0.7143 | 40 | 56 | 522,709 | 523,762 |
2019-12-01 | 0.2771 | 23 | 83 | 162,461 | 772,729 |
2019-09-01 | 0.2738 | 23 | 84 | 145,093 | 483,473 |
2019-06-01 | 0.4565 | 21 | 46 | 161,364 | 387,223 |
2019-03-01 | 1.1579 | 22 | 19 | 267,165 | 146,628 |
2018-12-01 | 0.5 | 6 | 12 | 62,678 | 123,999 |
2018-09-01 | 0.2917 | 7 | 24 | 70,620 | 656,005 |
2018-06-01 | 0.3684 | 7 | 19 | 69,048 | 1,193,526 |
2018-03-01 | 3.5714 | 25 | 7 | 1,183,048 | 76,984 |
2017-06-01 | 2.6667 | 8 | 3 | 188,358 | 167,143 |
2017-03-01 | 2.25 | 9 | 4 | 211,413 | 89,285 |
2016-09-01 | 1.0 | 3 | 3 | 149,998 | 149,998 |
2015-12-01 | 3.0 | 3 | 1 | 214,287 | 71,429 |
2015-06-01 | 11.0 | 11 | 1 | 1,210,881 | 10,000 |
2015-03-01 | 0.5 | 1 | 2 | 2,143 | 2,143 |
2014-03-01 | 1.0 | 4 | 4 | 6,642,810 | 3,321,405 |
2011-09-01 | 3.0 | 3 | 1 | 2,500,000 | 250,000 |
2006-06-01 | 1.2727 | 14 | 11 | 20,608,558 | 2,010,097 |
BioLife Solutions Notable Stakeholders
A BioLife Solutions stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as BioLife Solutions often face trade-offs trying to please all of them. BioLife Solutions' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting BioLife Solutions' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Michael Rice | CEO and President and Director | Profile | |
Aby Mathew | Chairman of Scientific Advisory Board, CTO and Sr. VP | Profile | |
Todd Berard | Vice President of Marketing | Profile | |
Karen Foster | Vice President - Operations | Profile | |
Roderick Greef | Interim CFO, Interim Secretary | Profile | |
Sarah JD | Chief Officer | Profile | |
Troy Wichterman | Chief Officer | Profile | |
Geraint Phillips | Senior Operations | Profile | |
Troy CPA | Chief Officer | Profile | |
Marcus Schulz | Chief Officer | Profile |
About BioLife Solutions Management Performance
The success or failure of an entity such as BioLife Solutions often depends on how effective the management is. BioLife Solutions management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of BioLife management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the BioLife management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.40) | (0.42) | |
Return On Capital Employed | (0.19) | (0.20) | |
Return On Assets | (0.16) | (0.17) | |
Return On Equity | (0.20) | (0.21) |
Please note, the imprecision that can be found in BioLife Solutions' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of BioLife Solutions. Check BioLife Solutions' Beneish M Score to see the likelihood of BioLife Solutions' management manipulating its earnings.
BioLife Solutions Workforce Analysis
Traditionally, organizations such as BioLife Solutions use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare BioLife Solutions within its industry.BioLife Solutions Manpower Efficiency
Return on BioLife Solutions Manpower
Revenue Per Employee | 350.3K | |
Revenue Per Executive | 14.3M | |
Net Loss Per Employee | 162.4K | |
Net Loss Per Executive | 6.6M | |
Working Capital Per Employee | 191.8K | |
Working Capital Per Executive | 7.8M |
Additional Tools for BioLife Stock Analysis
When running BioLife Solutions' price analysis, check to measure BioLife Solutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLife Solutions is operating at the current time. Most of BioLife Solutions' value examination focuses on studying past and present price action to predict the probability of BioLife Solutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLife Solutions' price. Additionally, you may evaluate how the addition of BioLife Solutions to your portfolios can decrease your overall portfolio volatility.